Arrowhead Pharmaceuticals Reports Fiscal 2024 Second Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 60.73 -2.02 (3.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $62.75 | 52 Week High | $8.22 | |||
| Open | $62.49 | 52 Week Low | $3.07 | |||
| Day High | $62.50 | P/E | N/A | |||
| Day Low | $60.48 | EPS | $-1.30 | |||
| Volume | 1,196,186 | |||||
